Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1114 | 1114 | 1177 | 1266 | 1643 | 4057 |
Fund Return | 11.37% | 11.37% | 17.68% | 8.18% | 10.44% | 15.03% |
Place in category | 1129 | 1129 | 2184 | 699 | 916 | 34 |
% in Category | 39 | 39 | 74 | 31 | 54 | 4 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity Feeder Class R EUR | 8.86B | 11.23 | 7.64 | 14.46 | ||
Fundsmith Equity Feeder R EUR Inc | 8.86B | 11.24 | 7.64 | 14.47 | ||
Fundsmith Equity Fund Feeder I EURi | 8.86B | 11.41 | 8.33 | 15.19 | ||
Fundsmith Equity Fund Feeder I EURe | 8.86B | 11.41 | 8.21 | 15.14 | ||
Fundsmith Equity Fund Feeder T EURe | 8.86B | 11.37 | 8.15 | 15.01 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fuzge | 13.36B | 7.92 | 4.45 | 10.19 | ||
Capital Group New Perspective Fube | 13.36B | 7.73 | 3.68 | 9.31 | ||
LU2133218979 | 13.36B | 8.01 | 4.60 | - | ||
Capital Group New Perspective Fubde | 13.36B | 7.74 | 3.68 | 9.30 | ||
Cap Group New Perspective lux N | 13.36B | 7.64 | 3.02 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 9.79 | 873.1 | -2.74% | |
Microsoft | US5949181045 | 9.35 | 397.84 | +0.73% | |
L'Oreal | FR0000120321 | 6.32 | 436.70 | -0.67% | |
Stryker | US8636671013 | 5.26 | 326.63 | -0.45% | |
Meta Platforms | US30303M1027 | 5.19 | 441.84 | +0.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review